# Pepper Bio's pitch deck

> Pepper Bio's pitch deck: 15 slides, and the funding round we observed afterwards.

Source: https://millionrounds.com/decks/pepper-bio (Millionrounds; every figure on the page links to its filing or article)

**Pepper Bio** Biopharma 1 / 15 Read in the app

Pitch deck

# Pepper Bio's *pitch deck*

The deck, and the round we watched Pepper Bio raise afterwards, with the investors each report named.

Pepper Bio is a biotechnology company based in Boston, founded in 2020. It is recognized as the world’s first transomics drug discovery company, utilizing AI and a proprietary database to uncover the root causes of diseases and expedite the development of effective treatments. The company operates with a dual business model, offering its AI-powered transomics platform to pharmaceutical companies and developing its own treatments for aggressive, untreatable cancers and other diseases. The core technology, known as the COMPASS platform, integrates four layers of biological data, genomics, transcriptomics, proteomics, and phosphoproteomics, to create a comprehensive map of cellular activity. This innovative approach allows researchers to identify new therapeutic targets and characterize potential drugs more effectively. Pepper Bio has secured exclusive global rights to develop and commercialize lerociclib, an oncology drug, and plans to begin clinical trials for its internal treatments following its recent funding round. The company collaborates with various partners, including Merck and G1 Therapeutics, to enhance drug discovery in complex disease areas.

15 slides 2.8MB US Biopharma

Read the deck Free account. The deck belongs to Pepper Bio, so reading it needs one; everything on this page is public.

What is in it

## The deck, slide by slide

Each slide by what it argues. 15 slides against a median of 13 across the 1,712 decks we hold.

*median*

- 1 **Cover**
- 2
- 3
- 4 **Solution**
- 5 **Problem**
- 6
- 7 **Product**
- 8 **Contact**
- 9 **Contact**
- 10
- 11 **Product**
- 12 **Product**
- 13 **Market**
- 14
- 15 **Product**

Cover Solution Problem Product Contact Market

What happened next

## $6.5M across 1 round

**1** rounds observed **$6.5M** reported in total **Nov 2023** first we saw **Nov 2023** most recent

- Nov 2023 Seed **$6.5M** [Mana Ventures](https://millionrounds.com/fund/mana-ventures)[NFX](https://millionrounds.com/fund/nfx)[Silverton Partners](https://millionrounds.com/fund/silverton-partners) Source recorded

[Everyone who backed Pepper Bio](https://millionrounds.com/company/pepper-bio)

Form D

What they told the regulator

## Pepper Bio filed 3 Form Ds with the SEC

The company reporting its own raise, rather than a journalist reporting it.

**$3.6M** sold under the offering **Jan 2023** most recent filing

1 / 15

The deck itself

## Read Pepper Bio's full pitch deck

All 15 slides, each read for what it argues and set against the decks that raised at the same stage. The cover is shown here; the rest is read in the app.

Read the deck *→* Free account. The deck belongs to Pepper Bio.

## More decks

[**Sano Genetics** Biopharma 1 / 13 **$26M** raised after](https://millionrounds.com/decks/sano-genetics)[**SpaceX** AI 1 / 15 **$42B** raised after](https://millionrounds.com/decks/spacex)[**Wework** Enterprise 1 / 36 **$12B** raised after](https://millionrounds.com/decks/wework)[**Uber** Transportation 1 / 25 **$11B** raised after](https://millionrounds.com/decks/uber)

[Browse all 1,712 decks](https://millionrounds.com/decks). We hold no record of where this file came from or on what terms. If it is yours and you would rather it were not here, [tell us](https://millionrounds.com/corrections?deck=pepper-bio) and it goes.